Description
Cagrilintide Technical Overview
Cagrilintide is an investigational long-acting analogue of amylin, a peptide hormone associated with metabolic regulation.
Amylin receptor signaling involves receptor complexes formed by the calcitonin receptor and receptor activity-modifying proteins (RAMPs).
Cagrilintide has been investigated in experimental and clinical studies of amylin receptor pharmacology, metabolic responses, and combination therapy research involving GLP-1 receptor agonists.
Compound Specifications
| Property | Value |
|---|---|
| Compound Name | Cagrilintide |
| Classification | Long-acting amylin analogue |
| Related Natural Hormone | Amylin |
| Research Target | Amylin receptor system |
| Related Receptor Components | Calcitonin receptor and RAMP proteins |
| Research Category | Metabolic and Endocrine Research |
| Vial Content | 5mg |
Storage and Handling
- Follow manufacturer-validated stability recommendations.
- Protect from moisture, direct light, and contamination.
- Use appropriate handling procedures for modified research peptides.
Lyophilized Format
Cagrilintide may be manufactured in lyophilized form. Stability depends on peptide modifications, formulation, and packaging.
Research Use Disclaimer
This Cagrilintide preparation is not represented as an FDA-approved pharmaceutical product and is not intended for human or veterinary administration.
Frequently Asked Questions
What Is Cagrilintide?
An investigational long-acting amylin analogue.
What Is Amylin?
A peptide hormone involved in metabolic and endocrine signaling.
Which Receptors Are Associated With Cagrilintide?
Amylin receptor complexes involving calcitonin receptors and RAMP proteins.
Is Cagrilintide the Same as Semaglutide?
No. They are structurally distinct compounds with different principal receptor targets.
What Research Areas Involve Cagrilintide?
Amylin receptor signaling, metabolic regulation, and peptide pharmacology.
Cagrilintide Research Overview
Cagrilintide has been investigated as a long-acting amylin analogue in metabolic research.
Amylin Receptor Signaling
Experimental research examines activation of amylin-associated receptor complexes.
Metabolic Regulation Research
Clinical studies have investigated Cagrilintide-associated metabolic outcomes under controlled conditions.
Combination Pharmacology
Research has also examined Cagrilintide in combination with GLP-1 receptor agonists such as Semaglutide.
Research Applications
| Research Area | In Vitro Application |
|---|---|
| Amylin Receptors | Receptor signaling assays |
| Peptide Pharmacology | Long-acting analogue characterization |
| Metabolic Research | Endocrine pathway studies |
References
- Lau DCW, Erichsen L, Francisco AM, et al. (2021). Once-Weekly Cagrilintide for Weight Management in People With Overweight and Obesity: A Randomised, Double-Blind, Placebo-Controlled and Active-Controlled Phase 2 Trial. The Lancet. Publication information.
Certificate of Analysis (COA)
Batch documentation should establish the compound’s molecular identity, chemical modifications, purity, and actual content.
Reviews
There are no reviews yet.